Deccan Health Care Ltd

542248

Overview

    • Equity Style Box

      Small Blend

    • Sector

      Healthcare

    • Industry

      Drug Manufacturers - Specialty & Generic

    • Day Range

      20.30 – 21.60

    • Year Range

      16.00 – 39.00

    • Market Cap

      509.5856 Mil

    • Volume / Avg

      21.8 k / 33.1 k

    • Price / Sales

      0.73

    • Price / Book

      0.47

    • Price / Earnings

      47.04

    • Forward Div Yield

      0.00%

    • Trailing Div Yield

      —

Login To Show Full Chart

Summary

Fair Value Assessment
Undervalued (38% Discount)
Fair ValueQ34.15UncertaintyHigh
Close Price21.17Jul 14, 2025
Market Closed
₹ 20.59
Price Down by 0.58 | 2.74 %
Trading Information Business Description
Previous Close
21.17
Day Range
20.30 – 21.60
Year Range
16.00 – 39.00
Bid / Ask
—
Market Cap
509.6 Mil
Volume / Average
21.8 k / 33.1 k
Beta (5-Year)
–
Shares Outstanding
24.75 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products including nutraceutical, cosmeceutical, and ayurveda products ( Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The Company is operating into a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries and the maximum of its revenue comes from India.
Contact
House No. 6-3-348/4, Dwarakapuri Colony Punjagutta, Hyderabad, TG 500082
T +91 4047096427
www.deccanhealthcare.co.in opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
57
As of Mar 31, 2024

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Mil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
750.58 750.58 597.29 450.22 331.76 337.76
Revenue Growth %
25.66% 25.66% 32.67% 35.72% -1.78% -20.05%
Gross Profit
275.60 275.60 190.33 183.49 173.11 144.55
Gross Profit Margin %
36.72% 36.72% 31.87% 40.76% 52.18% 42.80%
Operating Income
16.99 16.99 22.85 6.09 41.62 15.27
Operating Margin %
2.26% 2.26% 3.83% 1.35% 12.54% 4.52%
EBIT
17.04 17.04 22.56 5.90 6.51 5.88
EBIT Margin %
2.27% 2.27% 3.78% 1.31% 1.96% 1.74%
EBITDA
31.57 31.57 37.22 20.17 21.24 20.54
EBITDA Margin %
4.21% 4.21% 6.23% 4.48% 6.40% 6.08%
Net Income
11.59 11.59 14.93 3.64 3.23 3.90
Net Profit Margin %
1.54% 1.54% 2.50% 0.81% 0.97% 1.15%
Basic EPS
0.54 0.54 0.80 0.22 0.21 0.25
Diluted EPS
0.45 0.45 0.80 0.22 0.21 0.25
Normalized EPS
— — — — — —
Total Dividends per Share
— — — — — —
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Mil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
1,249.27 1,249.27 1,080.48 968.53 906.26 922.68
Total Liabilities
185.36 185.36 111.32 152.90 136.80 156.46
Total Debt
11.46 11.46 18.95 14.10 12.51 10.32
Total Equity
1,063.91 1,063.91 969.16 815.63 769.46 766.22
Cash And Cash Equivalents
35.54 35.54 26.03 14.34 26.68 32.23
Working Capital
905.45 905.45 806.87 638.77 574.70 537.46
Shares Outstanding (Mil)
— — — 17.04 15.71 —
Book Value Per Share
45.42 45.42 46.90 47.86 48.97 48.76
Total Debt To Equity
0.01 0.01 0.02 0.02 0.02 0.01
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Mil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
-64.27 -125.51 -66.06 -5.73 2.19 10.35
Cash From Investing Activities
-1.37 -3.00 2.51 -0.49 -0.72 -17.71
Cash From Financing Activities
75.15 140.44 51.21 0.67 -3.70 -2.96
Capital Expenditures
1.42 3.11 — 1.12 1.58 18.11
Free Cash Flow
27.89 25.03 9.72 16.48 16.80 97.25
Change in Cash
9.51 11.93 -12.34 -5.55 -2.23 -10.33

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

There is no Ownership data available.

STOCKS
MUTUAL FUNDS
ADITYABIRLAAXISBajajBANDHANBARODABNPBOICANARADSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top